tert-Butyl (6-chloro-9H-purin-2-yl)carbamate

Catalog No. :
ACKIPV092
CAS No. :
309947-89-5
Molecular Formula :
C10H12ClN5O2
Molecular Weight :
269.69

IUPAC Name:tert-butyl (6-chloro-9H-purin-2-yl)carbamate

tert-Butyl (6-chloro-9H-purin-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$100.00Login to see priceIn stockInquiry
250mg95%$169.00Login to see priceIn stockInquiry
1g95%$453.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (6-chloro-9H-purin-2-yl)carbamate
IUPAC Nametert-butyl (6-chloro-9H-purin-2-yl)carbamate
MDL No.MFCD18375345
Molecular FormulaC10H12ClN5O2
Molecular Weight269.69
SMILESO=C(OC(C)(C)C)NC1=NC(Cl)=C2N=CNC2=N1
InChI KeyFVZGELOMTPFKMY-UHFFFAOYSA-N
Synonymtert-butyl N-(6-chloro-9H-purin-2-yl)carbamate;tert-butyl N-(6-chloro-7H-purin-2-yl)carbamate;Carbamic acid, N-(6-chloro-9H-purin-2-yl)-, 1,1-dimethylethyl ester;tert-butyl (6-chloro-9H-purin-2-yl)carbamate;N-Boc-6-chloro-9H-purin-2-amine
CAS No.309947-89-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKIPV092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIPV092 route product structure diagram
    ACKIPV092309947-89-5 In Stock
Inquiry

2. ACKIPV092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIGFL096 route compound structure diagram
    ACIGFL09610310-21-1 In Stock
  4. Then
  5. ACKIPV092 route product structure diagram
    ACKIPV092309947-89-5 In Stock
Inquiry

Comments (0)